Showing results (2911-2920 of 11,119) with videos related to
Sort By:
Pageof 1,112
Journal of Neurology|October 29, 2013
Impact of cerebro-spinal fluid biomarkers of Alzheimer's disease in clinical practice: a multicentric studyFrançois Mouton-Liger, David Wallon, Anne-Cécile Troussière, et al.Journal of Neurology|August 24, 2014
Subcutaneous immunoglobulin in CIDP and MMN: a short-term nationwide studyDario Cocito, Aristide Merola, Erdita Peci, et al.Journal of Neurology|August 24, 2014
Novel EXOSC3 mutation causes complicated hereditary spastic paraplegiaAyelet Halevy, Israela Lerer, Rony Cohen, et al.Journal of Neurology|September 4, 2014
Screening for dopa-responsive dystonia in patients with Scans Without Evidence of Dopaminergic Deficiency (SWEDD)Anna De Rosa, Claudia Carducci, Carla Carducci, et al.Journal of Neurology|March 3, 2016
Validation of the MG-DIS: a disability assessment for myasthenia gravisAlberto Raggi, Matilde Leonardi, Silvia Schiavolin, et al.Journal of Neurology|March 12, 2016
Long-term impact on quality of life of subthalamic nucleus stimulation in Parkinson's diseaseElena Lezcano, Juan Carlos Gómez-Esteban, Beatriz Tijero, et al.Journal of Neurology|April 27, 2016
Feasibility of external rhythmic cueing with the Google Glass for improving gait in people with Parkinson's diseaseYan Zhao, Jorik Nonnekes, Erik J M Storcken, et al.Journal of Neurology|April 27, 2016
Voxel-based meta-analysis of gray matter volume reductions associated with cognitive impairment in Parkinson's diseaseYaqian Xu, Jing Yang, Xinyu Hu, et al.Journal of Neurology|November 5, 2015
Autonomic dysfunction in subjects at high risk for Parkinson's diseaseInga Liepelt-Scarfone, Andrea Pilotto, Katharina Müller, et al.Journal of Neurology|January 1, 1985
Cerebrospinal fluid in multiple sclerosis: relationships between immunoglobulins, leucocytes and clinical featuresR W Walker, E J Thompson, W I McDonaldPageof 1,112